Funding for this research was provided by:
National Health and Medical Research Council (1102532)
Received: 7 September 2018
Accepted: 30 December 2019
First Online: 11 February 2020
Ethics approval and consent to participate
: Ethics approval for this study was requested and approved through the Western Sydney University Human Research Ethics Committee (HREC; Approval H12091). All participants were provided with a copy of the participant information sheet and consent form, and informed consent was obtained from all participants prior to commencing data collection: verbal consent was obtained for GPs as these interviews were conducted via telephone, and written consent was obtained for community forums as these were conducted face-to-face; this consent procedure was approved by the HREC.
: As a medical research institute, NICM Health Research Institute receives research grants and donations from foundations, universities, government agencies, individuals and industry. Sponsors and donors provide untied funding for work to advance the vision and mission of the Institute. The project that is the subject of this article was not undertaken as part of a contractual relationship with any organisation other than the funding declared above. It should also be noted that NICM conducts clinical trials relevant to this topic area, for which further details can be provided on request. MIH has received educational travel grants from Amgen. The remaining authors declare no competing interests.